Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis
Dihydropyrimidine dehydrogenase (DPD) deficiency is associated with severe fluoropyrimidines-induced toxicity. As of September 2018, French recommendations call for screening for DPD deficiency by plasma uracil quantification prior to all fluoropyrimidine-based chemotherapy. A dose reduction of fluo...
Saved in:
Main Authors: | Nicolas Laures (Author), Céline Konecki (Author), Mathias Brugel (Author), Anne-Lise Giffard (Author), Naceur Abdelli (Author), Damien Botsen (Author), Claire Carlier (Author), Claire Gozalo (Author), Catherine Feliu (Author), Florian Slimano (Author), Zoubir Djerada (Author), Olivier Bouché (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
by: Antoine Le Bozec, et al.
Published: (2023) -
Dihydropyrimidine dehydrogenase deficiency as a cause of fatal 5-Fluorouracil toxicity
by: Shiraz S. Fidai, et al.
Published: (2018) -
Development and Validation of a Non-Targeted Screening Method for Most Psychoactive, Analgesic, Anaesthetic, Anti-Diabetic, Anti-Coagulant and Anti-Hypertensive Drugs in Human Whole Blood and Plasma Using High-Resolution Mass Spectrometry
by: Catherine Feliu, et al.
Published: (2023) -
Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring
by: Catherine Feliu, et al.
Published: (2021) -
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
by: Jihyun Kang, et al.
Published: (2022)